πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 17 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11850259

Methods of treating viral infections affecting the respiratory tract using topically admin

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11207429

Method and compositions for orally administered contrast agents for MR imaging

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10478505

Edible oils to enhance delivery of orally administered steroids

The Regents of the University of California Β· Granted Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697048

Peptide amphiphile suspension to prevent or reduce tumor formation from administered embry

Northwestern University Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8404635

Orally administered peptides synergize statin activity

The Regents of the University of California Β· Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7820784

Orally administered peptides synergize statin activity

The Regents of the University of California Β· Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7807640

Orally administered peptides synergize statin activity

The Regents of the University of California Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7531514

Orally administered peptides synergize statin activity

The Regents of the University of California Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7199102

Orally administered peptides synergize statin activity

The Regents of the University of California Β· Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7166578

Orally administered peptides synergize statin activity

The Regents of the University of California Β· Granted Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7148197

Orally administered small peptides synergize statin activity

The Regents of the University of California Β· Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7144862

Orally administered peptides to ameliorate atherosclerosis

The Regents of the University of California Β· Granted Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 6933279

Orally administered peptides to ameliorate atherosclerosis

The Regents of the University of California Β· Granted Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6752996

Use of parapox PP30 protein to modify immune responses to administered antigens

The Board of Regents of the University of Texas System Β· Granted Tue Jun 22 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6723329

Use of parapox B2L protein to modify immune responses to administered antigens

The Board of Regents of the University of Texas System Β· Granted Tue Apr 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6664230

Orally administered peptides to ameliorate atherosclerosis

The Regents of the University of California Β· Granted Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6010691

Methods for enhancing permeation of a topically administered physiologically active substa

The Regents of the University of California Β· Granted Tue Jan 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

expired